<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
      <journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
      <journal-id journal-id-type="hwp">pnas</journal-id>
      <journal-id journal-id-type="pmc">pnas</journal-id>
      <journal-id journal-id-type="publisher-id">PNAS</journal-id>
      <journal-title-group>
        <journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0027-8424</issn>
      <issn pub-type="epub">1091-6490</issn>
      <publisher>
        <publisher-name>National Academy of Sciences</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25918406</article-id>
      <article-id pub-id-type="pmc">4434742</article-id>
      <article-id pub-id-type="publisher-id">201422340</article-id>
      <article-id pub-id-type="doi">10.1073/pnas.1422340112</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Biological Sciences</subject>
          <subj-group>
            <subject>Microbiology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Cas9-mediated targeting of viral RNA in eukaryotic cells</article-title>
        <alt-title alt-title-type="short">Cas9-mediated RNA targeting in eukaryotic cells</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Price</surname>
            <given-names>Aryn A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>c</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sampson</surname>
            <given-names>Timothy R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>c</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn1">
            <sup>1</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ratner</surname>
            <given-names>Hannah K.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>c</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Grakoui</surname>
            <given-names>Arash</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>c</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>d</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Weiss</surname>
            <given-names>David S.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>c</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>d</sup>
          </xref>
          <xref ref-type="aff" rid="aff5">
            <sup>e</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>3</sup>
          </xref>
        </contrib>
        <aff id="aff1"><sup>a</sup>Department of Microbiology and Immunology, Microbiology and Molecular Genetics Program,</aff>
        <aff id="aff2"><sup>b</sup>Emory Vaccine Center, and</aff>
        <aff id="aff3"><sup>c</sup>Yerkes National Primate Research Center, <institution>Emory University</institution>, Atlanta, <addr-line>GA</addr-line> 30329; and</aff>
        <aff id="aff4"><sup>d</sup>Division of Infectious Diseases and</aff>
        <aff id="aff5"><sup>e</sup>Emory Antibiotic Resistance Center, Department of Medicine, <institution>Emory University School of Medicine</institution>, Atlanta, <addr-line>GA</addr-line> 30329</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><sup>3</sup>To whom correspondence may be addressed. Email: <email>david.weiss@emory.edu</email> or <email>arash.grakoui@emory.edu</email>.</corresp>
        <fn fn-type="edited-by">
          <p>Edited by Scott J. Hultgren, Washington University School of Medicine, St. Louis, MO, and approved April 8, 2015 (received for review November 24, 2014)</p>
        </fn>
        <fn fn-type="con">
          <p>Author contributions: A.A.P., T.R.S., H.K.R., A.G., and D.S.W. designed research; A.A.P., T.R.S., and H.K.R. performed research; A.A.P., T.R.S., H.K.R., A.G., and D.S.W. analyzed data; and A.A.P., T.R.S., H.K.R., A.G., and D.S.W. wrote the paper.</p>
        </fn>
        <fn fn-type="equal" id="fn1">
          <p><sup>1</sup>A.A.P. and T.R.S. contributed equally to this work.</p>
        </fn>
        <fn fn-type="present-address" id="fn2">
          <p><sup>2</sup>Present address: Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>12</day>
        <month>5</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>4</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>27</day>
        <month>4</month>
        <year>2015</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
      <volume>112</volume>
      <issue>19</issue>
      <fpage>6164</fpage>
      <lpage>6169</lpage>
      <permissions>
        <license license-type="open-access">
          <license-p>Freely available online through the PNAS open access option.</license-p>
        </license>
      </permissions>
      <self-uri xlink:title="pdf" xlink:href="pnas.201422340.pdf"/>
      <abstract abstract-type="executive-summary">
        <title>Significance</title>
        <p>The clustered, regularly interspaced, short palindromic repeats associated endonuclease, Cas9, has quickly become a revolutionary tool in genome engineering. Utilizing small guiding RNAs, Cas9 can be targeted to specific DNA sequences of interest, where it catalyzes DNA cleavage. We now demonstrate that Cas9 from the Gram-negative bacterium <italic>Francisella novicida</italic> (FnCas9) can be reprogrammed to target a specific RNA substrate, the genome of the +ssRNA virus, hepatitis C virus, in eukaryotic cells. Further, this targeting results in inhibition of viral protein production. Overall, programmable Cas9-mediated viral RNA targeting likely represents one of myriad potential applications of FnCas9 in RNA targeting in eukaryotic cells.</p>
      </abstract>
      <abstract>
        <p>Clustered, regularly interspaced, short palindromic repeatsâ€“CRISPR associated (CRISPR-Cas) systems are prokaryotic RNA-directed endonuclease machineries that act as an adaptive immune system against foreign genetic elements. Using small CRISPR RNAs that provide specificity, Cas proteins recognize and degrade nucleic acids. Our previous work demonstrated that the Cas9 endonuclease from <italic>Francisella novicida</italic> (FnCas9) is capable of targeting endogenous bacterial RNA. Here, we show that FnCas9 can be directed by an engineered RNA-targeting guide RNA to target and inhibit a human +ssRNA virus, hepatitis C virus, within eukaryotic cells. This work reveals a versatile and portable RNA-targeting system that can effectively function in eukaryotic cells and be programmed as an antiviral defense.</p>
      </abstract>
      <kwd-group>
        <kwd>Cas9</kwd>
        <kwd>CRISPR-Cas</kwd>
        <kwd>hepatitis C virus</kwd>
        <kwd>RNA targeting</kwd>
        <kwd>Francisella</kwd>
      </kwd-group>
      <funding-group>
        <award-group id="gs1">
          <funding-source id="sp1">HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)<named-content content-type="funder-id">100000060</named-content></funding-source>
          <award-id rid="sp1">R01-AI11070</award-id>
        </award-group>
        <award-group id="gs2">
          <funding-source id="sp2">HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)<named-content content-type="funder-id">100000060</named-content></funding-source>
          <award-id rid="sp2">U54-AI057157</award-id>
        </award-group>
        <award-group id="gs3">
          <funding-source id="sp3">HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)<named-content content-type="funder-id">100000060</named-content></funding-source>
          <award-id rid="sp3">R01-AI070101</award-id>
        </award-group>
        <award-group id="gs4">
          <funding-source id="sp4">HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<named-content content-type="funder-id">100000062</named-content></funding-source>
          <award-id rid="sp4">R01-DK083356</award-id>
        </award-group>
      </funding-group>
      <counts>
        <page-count count="6"/>
      </counts>
    </article-meta>
  </front>
</article>

